Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target

OA Sukocheva, H Furuya, ML Ng, M Friedemann… - Pharmacology & …, 2020 - Elsevier
Inflammatory gastrointestinal (GI) diseases and malignancies are associated with growing
morbidity and cancer-related mortality worldwide. GI tumor and inflammatory cells contain …

[HTML][HTML] The oncogenic role of Jagged1/Notch signaling in cancer

M Xiu, Y Liu, B Kuang - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Aberrant activation of Notch signaling plays an oncogenic role in cancer development.
Jagged1 (JAG1) is an important Notch ligand that triggers Notch signaling through cell-cell …

LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p

S Zhou, L Yu, M Xiong, G Dai - Biochemical and biophysical research …, 2018 - Elsevier
Osteosarcoma is the most common primary malignant bone tumor and has a high fatality
rate in children and adolescents. Recently, an increasing amount of evidence has …

Notch1 in cancer therapy: possible clinical implications and challenges

L Gharaibeh, N Elmadany, K Alwosaibai… - Molecular pharmacology, 2020 - ASPET
The Notch family consists of four highly conserved transmembrane receptors. The release of
the active intracellular domain requires the enzymatic activity of γ-secretase. Notch is …

[HTML][HTML] Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis

X Wang, Y Li, Y Dai, Q Liu, S Ning, J Liu, Z Shen… - Scientific Reports, 2016 - nature.com
Gastric carcinoma (GC) is the second leading cause of cancer-related mortality worldwide.
The efficacy of standard chemotherapy for GC, such as cisplatin (CDDP), is dissatisfactory …

Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers

G Zhou, O Latchoumanin, L Hebbard, W Duan… - Advanced drug delivery …, 2018 - Elsevier
Traditional anticancer therapies are often unable to completely eradicate the tumor bulk due
to multi-drug resistance (MDR) of cancers. A number of mechanisms such as micro …

MicroRNA‐124: an emerging therapeutic target in cancer

X Jia, X Wang, X Guo, J Ji, G Lou, J Zhao… - Cancer …, 2019 - Wiley Online Library
MicroRNAs (miRNAs) are noncoding single‐stranded RNAs, approximately 20‐24
nucleotides in length, known as powerful posttranscriptional regulators. miRNAs play …

[HTML][HTML] NEAT1/miR‑124/STAT3 feedback loop promotes breast cancer progression

Y Pang, J Wu, X Li, C Wang… - … journal of oncology, 2019 - spandidos-publications.com
The long non‑coding RNA nuclear enriched abundant transcript 1 (NEAT1) has important
roles in the regulation of multiple cell functions, such as proliferation, apoptosis and …

LncRNA HOTAIR promotes renal interstitial fibrosis by regulating Notch1 pathway via the modulation of miR‐124

H Zhou, L Gao, Z Yu, S Hong, Z Zhang, Z Qiu - Nephrology, 2019 - Wiley Online Library
Aim To understand the mechanism of long non‐coding RNA (LncRNA) HOTAIR on renal
interstitial fibrosis (RIF) by regulating Notch1 pathway via the modulation of miR‐124 …

miR-124: a promising therapeutic target for central nervous system injuries and diseases

J Xu, Y Zheng, L Wang, Y Liu, X Wang, Y Li… - Cellular and molecular …, 2022 - Springer
Central nervous system injuries and diseases, such as ischemic stroke, spinal cord injury,
neurodegenerative diseases, glioblastoma, multiple sclerosis, and the resulting …